KN

Karl Nocka

SR Sloan Kettering Institute For Cancer Research: 5 patents #84 of 644Top 15%
US Ucb S.A.: 2 patents #46 of 218Top 25%
CY Cytomed: 1 patents #13 of 19Top 70%
Pfizer: 1 patents #3,022 of 5,153Top 60%
📍 Harvard, MA: #58 of 258 inventorsTop 25%
🗺 Massachusetts: #14,132 of 88,656 inventorsTop 20%
Overall (All Time): #562,010 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
10544212 Anti-IL-33 antibodies, compositions, methods and uses thereof Laird Bloom, James R. Apgar, Matthew Allister Lambert, Mark A. FARMER 2020-01-28
7465549 Methods for identifying agents that bind a levetiracetam binding site (LBS) or compete with LEV binding to a LBS of a synaptic vesicle protein 2 (SV2) Berkley A. Lynch, Bruno Fuks 2008-12-16
7090985 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases Berkley A. Lynch, Bruno Fuks 2006-08-15
6403559 C-kit ligand-based method for expanding peripheral blood cell levels Peter Besmer, Jochen Buck, Malcolm A. S. Moore 2002-06-11
6159461 Use of c-kit ligand with TNF-.alpha. and hematopoietic factors for the expansion or differentiation of hematopoietic cells Peter Besmer, Jochen Buck, Malcolm A. S. Moore 2000-12-12
6001803 Composition of c-kit ligand, GM-CSF, and TNF-.alpha. and method of use Peter Besmer, Jochen Buck, Malcolm A. S. Moore 1999-12-14
5935565 Method for increasing the level of stem cells in peripheral blood Peter Besmer, Jochen Buck, Malcolm A. S. Moore 1999-08-10
5767074 Compositions of soluble C-kit ligand and hematopoietic factors Peter Besmer, Jochen Buck, Malcolm A. S. Moore 1998-06-16
5525708 Covalent dimer of kit ligand Robert Lobell 1996-06-11